Abstract:Background The majority of autoimmune diseases, e.g. rheumatoid arthritis (RA), are characterized by autoantibodies that are produced by B cells. We have identified several novel post-translationally modified epitopes in collagen type II (CII), a major cartilage constituent that are autoreactive. In mouse models, autoantibodies that bind to these epitopes can either induce or protect against inflammatory arthritis. However, very little is known about the frequencies or phenotype the B cells that produce these autoantibodies in humans. Objectives The aim of this project is to study the B cells that produce autoantibodies reactive to CII-epitopes in patients with RA. Methods Clinical data and peripheral blood were collected from patients with RA (n=100). Titres of CII-reactive serum-autoantibodies were determined by Luminex. The different subsets of B cells that expressed a CII-reactive B cell receptor (BCR) were analysed and isolated in patients with positive (n=10) or negative (n=5) titres for autoantibodies recognizing the CII-epitopes cyc48 (CII-F4-R-Cit) and cyc49 (CII-F4-Cit-R) as well as in healthy controls (n=3) using flow cytometry. Results In patients with detectable autoantibodies to cyc48 and cyc49, their titres were 13761±3815 and 5585±1992 (mean ± SEM), respectively. The corresponding titres in the patients negative for these autoantibodies were 122±55 and 234±75. In autoantibody-positive patients, the frequencies of cells expressing a BCR reactive for cyc48 and cyc49 in different subsets were: transitional cells 0.88±0.18% and 1.33±0.33%; naïve cells 0.09±0.0008% and 0.13±0.06 and memory cells 0.31±0.25 and 0.30±0.12%. All frequencies were well above those detected in patients without cyc48/49 titres and in healthy controls. A higher proportion (p=0.03) of the cyc48/49 positive patients were treated with methotrexate compared to cyc48/49 negative patients, no other clinical differences were recorded. CII-reactive single B cells were isolated in order to clone the BCR Conclusions In patients with manifest RA there is a relatively high and detectable frequency of transitional B cells that express a joint-specific BCR, which suggests that the deletion of autoreactive B cells in the bone marrow in RA patients is defective. As there is a decrease in the proportion of naïve CII-specific B cells, a substantial amount of the autoreactive cells are deleted in the periphery. However, peripheral B-cell tolerance is incomplete, as CII-specific B cells are enriched in the pool of memory B cells. Disclosure of Interest None declared

The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4

A Novel Hla-Drb1*10:01-Restricted T Cell Epitope from Citrullinated Type Ii Collagen Relevant to Rheumatoid Arthritis

Multiple Antibody Reactivities to Citrullinated Antigens in Sera from Patients with Rheumatoid Arthritis: Association with HLA-DRB1 Alleles

Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis

The HLA‐DRB1 Shared Epitope is Not Associated with Antibodies Against Cyclic Citrullinated Peptide in Chinese Patients with Rheumatoid Arthritis

Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor

Genetic and Environmental Determinants for Disease Risk in Subsets of Rheumatoid Arthritis Defined by the Anticitrullinated Protein/peptide Antibody Fine Specificity Profile

Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis

Predominant Selection of T Cells Specific for the Glycosylated Collagen Type II Epitope (263-270) in Humanized Transgenic Mice and in Rheumatoid Arthritis.

Structural Basis of Cross‐Reactivity of Anti–Citrullinated Protein Antibodies

Multifunctional T Cell Reactivity to Native and Glycosylated Type-II Collagen in Rheumatoid Arthritis.

Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides

Structure and Pathogenicity of Antibodies Specific for Citrullinated Collagen Type Ii in Experimental Arthritis

The Impact of Glycosylation on Hla-Dr1-Restricted T Cell Recognition of Type Ii Collagen in A Mouse Model

Impact of Citrullination Upon Antigenicity of Fibrinogen

[T Cell Proliferative Response and Antibody Formation to Citrullinated Collagen Type II in Patients with Rheumatoid Arthritis].

Association of HLA-DRB1 alleles with the levels of anti-cyclic citrullinated peptide antibody and rheumatoid factor in rheumatoid arthritis

Association Between Protein Tyrosine Phosphatase 22 Variant R620W in Conjunction with the HLA-DRB1 Shared Epitope and Humoral Autoimmunity to an Immunodominant Epitope of Cartilage-Specific Type II Collagen in Early Rheumatoid Arthritis.

A structural basis of T cell cross-reactivity to native and spliced self-antigens presented by HLA-DQ8

SAT0031 Detection and Isolation of Antigen Specific B Cells in Patients with Rheumatoid Arthritis

Identification of Loci Genetically Associated with Antibodies to Specific Sets of Citrullinated Peptides in Rheumatoid Arthritis Patients